CN111214549A - Nasal cavity nursing spray and preparation method thereof - Google Patents

Nasal cavity nursing spray and preparation method thereof Download PDF

Info

Publication number
CN111214549A
CN111214549A CN202010163052.6A CN202010163052A CN111214549A CN 111214549 A CN111214549 A CN 111214549A CN 202010163052 A CN202010163052 A CN 202010163052A CN 111214549 A CN111214549 A CN 111214549A
Authority
CN
China
Prior art keywords
parts
solution
nasal
leaf
nasal cavity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010163052.6A
Other languages
Chinese (zh)
Inventor
卞龙艳
朱慧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Vocational College of Medicine
Original Assignee
Jiangsu Vocational College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Vocational College of Medicine filed Critical Jiangsu Vocational College of Medicine
Priority to CN202010163052.6A priority Critical patent/CN111214549A/en
Publication of CN111214549A publication Critical patent/CN111214549A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489Sophora, e.g. necklacepod or mamani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/532Agastache, e.g. giant hyssop
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • A61K36/575Magnolia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a nasal cavity nursing spray which is prepared from the following raw materials in parts by weight: 6-8 parts of centipeda minima, 3-5 parts of eucalyptus leaf extract, 2-4 parts of bay leaf extract, 3-5 parts of sandalwood extract, 4-6 parts of magnolia flower, 8-12 parts of menthol, 5-7 parts of plant cellulose, 1-3 parts of radix scutellariae, 6-8 parts of radix sophorae flavescentis, 5-7 parts of agastache rugosus and 1-3 parts of isotonic regulator. The invention not only can inhibit bacteria and diminish inflammation, but also can keep the inner surface of the nasal cavity moist for a long time, is beneficial to human health, has simple preparation process, no pollution and energy conservation, and is suitable for industrial implementation.

Description

Nasal cavity nursing spray and preparation method thereof
Technical Field
The invention relates to the technical field of nasal cavity sprays, in particular to a nasal cavity nursing spray and a preparation method thereof.
Background
Rhinitis, an inflammatory disease of the nasal cavity, is inflammation of the mucous membrane of the nasal cavity caused by viruses, bacteria, allergens, various physicochemical factors and certain systemic diseases. The main pathological changes of rhinitis are congestion, swelling, exudation, hyperplasia, atrophy or necrosis of the nasal mucosa. Clinical symptoms include nasal obstruction, nasal discharge, hyposmia, headache, dizziness, etc. In addition, rhinitis, an inflammatory disease of the nasal cavity, refers to inflammation of the nasal mucosa and submucosal tissues, which is variously represented. Inflammation of nasal mucosa is generally caused by virus, bacteria, fungi, allergens, various physicochemical factors and systemic lesions. The rhinitis can be divided into a plurality of types according to different division angles, and from the pathological changes of nasal mucosa, the rhinitis comprises chronic simple rhinitis, chronic hypertrophic rhinitis, caseous rhinitis, atrophic rhinitis and the like, and from the aspects of urgency and slowness of onset and length of disease course, the rhinitis can be divided into acute rhinitis and chronic rhinitis. Allergic rhinitis (that is, allergic rhinitis) and rhinitis medicamentosa are the causes of the disease. However, whatever the cause of rhinitis, the main pathological changes are congestion, swelling and exudation of nasal mucosa; hyperplasia, atrophy, or necrosis, etc., wherein viral infection is the primary cause, and secondary bacterial infection is the basis of viral infection, and more than 100 viruses are known to cause the disease, the most common rhinovirus, coronavirus, coxsackie virus, and myxovirus and paramyxovirus, etc. Viral transmission is mainly from breathing to inhalation, and people usually use oral drugs or drug sprays to treat rhinitis, and also use nasal sprays to clean nasal cavities to relieve part of symptoms.
The existing nasal cavity spray is mainly used for sterilization and disinfection, and mainly comprises physiological saline, bactericides such as aspirin, ibuprofen, chlorpheniramine and other antibiotic medicines are added, although the nasal cavity cleaning solution can effectively kill most germs and has a certain sterilization and disinfection effect on nasal cavities, the side effect and the medication hazard degree to human bodies are increased by neglecting the use of medicines and antibiotic medicines for cleaning or sterilizing the nasal cavities, and most products in the market have single effect, the maintenance time for flushing the nasal cavities is short when the nasal cavities are used, some patients with dry, itchy and astringent nose often just spray the nasal cavities soon, the nose recovers the dry and itchy state again, and the use frequency of individual patients is increased due to the need of working or other aspects, so that inconvenience is brought to life, the nasal cavity bearing pressure is increased, and the nasal cavity patients can achieve the expected effect when the products are not used, have to be used continuously, which causes a lot of unnecessary troubles.
Disclosure of Invention
Aiming at the defects, the invention aims to provide a nasal cavity nursing spray and a preparation method thereof, which can inhibit bacteria and diminish inflammation, can keep the inner surface of a nasal cavity moist for a long time, are beneficial to human health, have simple preparation process, are free from pollution, save energy and are suitable for industrial implementation.
The invention is realized by the following technical scheme:
a nasal care spray characterized by: the composition is characterized by comprising the following raw materials in parts by weight: 6-8 parts of centipeda minima, 3-5 parts of eucalyptus leaf extract, 2-4 parts of bay leaf extract, 3-5 parts of sandalwood extract, 4-6 parts of magnolia flower, 8-12 parts of menthol, 5-7 parts of plant cellulose, 1-3 parts of radix scutellariae, 6-8 parts of radix sophorae flavescentis, 5-7 parts of agastache rugosus and 1-3 parts of isotonic regulator.
As an improvement of the technical proposal, the plant cellulose is prepared by smashing wheat bran and inorganic acid into pulp to prepare α -cellulose, then processing the α -cellulose to partially depolymerize the cellulose, and then removing non-crystalline parts and purifying the α -cellulose.
As an improvement of the above technical scheme, the eucalyptus leaf extract, the laurel leaf extract and the sandalwood extract are water saturated solutions prepared by respectively extracting fresh eucalyptus leaves, laurel leaves and sandalwood leaves by a distillation extraction method.
As an improvement of the technical scheme, the preparation method of the nasal cavity care spray comprises the following steps:
step 1: mixing herba Centipedae, flos Magnoliae, Mentholum, plant cellulose, Scutellariae radix, radix Sophorae Flavescentis and herba Agastaches, pulverizing to 40-80 mesh, adding 8-12 times of 85% ethanol, soaking at 55-65 deg.C for 12-24 hr, filtering, and collecting filtrate; reflux-extracting the residue with 6-8 times of 95% ethanol at 65-85 deg.C for 5-7 hr, filtering, mixing filtrates, and concentrating under reduced pressure to 0.2-0.5g/ml to obtain solution A;
step 2: mixing the folium Eucalypti Globueli extractive solution, laurel leaf extractive solution and lignum Santali albi extractive solution at corresponding ratio, shaking at low frequency for 3-5 min, and filtering with filter to obtain solution B;
and step 3: mixing the obtained solution A and solution B, and oscillating at low frequency;
and 4, step 4: placing the isoosmotic adjusting agent into the mixed solution obtained in the step (3), and stirring the mixed solution for 3-5 minutes by using a magnetic stirrer;
and 5: carrying out electrode treatment on the mixed solution obtained in the step 4 every 3 minutes; the electrode treatment is to place the mixed reaction solution in a lower electrode medium of a plasma device with the voltage of 18kV, the current of 1.2mA and the gap of 3 mm;
step 6: and (5) sterilizing the solution obtained in the step (5), and sealing and preserving.
As an improvement of the technical proposal, the solution obtained is irradiated by an ultraviolet light source to kill the microorganisms in the solution.
The invention has the beneficial effects that:
according to the scheme, the type of a bactericide in the nasal spray is changed, the traditional aspirin, ibuprofen, chlorphenamine and other antibiotic medicines are replaced by natural bactericidal and anti-inflammatory substances in plants such as eucalyptus leaves, bay leaves, sandalwood and the like, side effects on a human body are reduced, medicine resistance cannot be generated by bacteria in nasal cavities, a special preparation process is adopted to change the molecular selective permeability of the medicines, so that the spray forms a moisturizing membrane on the inner wall of the nasal cavity, the durability of cleaning and moisturizing the nasal cavity is improved on the premise that nasal germs are eliminated, the nasal cavity is kept clean and moist for a long time, the expected effect of the product is improved, and the pressure of a patient who is troubled to use the nasal spray is relieved better. In addition, the centipeda minima can treat stuffy nose and obstruction, nasosinusitis and watery nasal discharge, the menthol is used as an irritant in medicine and acts on skin or mucous membrane to achieve the effects of cooling and relieving itching, the magnolia flower can treat acute and chronic rhinitis, allergic rhinitis, hypertrophic rhinitis, nasosinusitis, paranasal sinusitis and the like, and the centipeda minima has the advantages of outstanding curative effect, high cure rate, simplicity, low cost and easiness in clinical popularization by matching with other medicinal auxiliary materials.
Detailed Description
Example 1:
a nasal care spray characterized by: the composition is characterized by comprising the following raw materials in parts by weight: 7 parts of centipeda minima, 4 parts of eucalyptus leaf extract, 3 parts of bay leaf extract, 4 parts of sandalwood extract, 5 parts of magnolia flower, 10 parts of menthol, 6 parts of plant cellulose, 2 parts of radix scutellariae, 7 parts of radix sophorae flavescentis, 6 parts of agastache rugosus and 2 parts of an isoosmotic adjusting agent.
wherein the plant cellulose is prepared by mashing wheat bran and inorganic acid into slurry to obtain α -cellulose, treating to partially depolymerize cellulose, removing non-crystalline part, and purifying.
The Eucalyptus leaf extractive solution, the laurel leaf extractive solution and the sandalwood extractive solution are water saturated solutions prepared by respectively extracting fresh Eucalyptus leaf, laurel leaf and sandalwood leaf by a distillation extraction method.
Specifically, the preparation method of the nasal cavity care spray comprises the following steps:
step 1: mixing herba Centipedae, flos Magnoliae, Mentholum, plant cellulose, Scutellariae radix, radix Sophorae Flavescentis and herba Agastaches, pulverizing to 40-80 mesh, adding 8-12 times of 85% ethanol, soaking at 55-65 deg.C for 12-24 hr, filtering, and collecting filtrate; reflux-extracting the residue with 6-8 times of 95% ethanol at 65-85 deg.C for 5-7 hr, filtering, mixing filtrates, and concentrating under reduced pressure to 0.2-0.5g/ml to obtain solution A;
step 2: mixing the folium Eucalypti Globueli extractive solution, laurel leaf extractive solution and lignum Santali albi extractive solution at corresponding ratio, shaking at low frequency for 3-5 min, and filtering with filter to obtain solution B;
and step 3: mixing the obtained solution A and solution B, and oscillating at low frequency;
and 4, step 4: placing the isoosmotic adjusting agent into the mixed solution obtained in the step (3), and stirring the mixed solution for 3-5 minutes by using a magnetic stirrer;
and 5: carrying out electrode treatment on the mixed solution obtained in the step 4 every 3 minutes; the electrode treatment is to place the mixed reaction solution in a lower electrode medium of a plasma device with the voltage of 18kV, the current of 1.2mA and the gap of 3 mm;
step 6: and (5) sterilizing the solution obtained in the step (5), and sealing and preserving.
Finally, the solution is irradiated by an ultraviolet light source, and the microorganisms in the solution are killed.
According to the scheme, the type of a bactericide in the nasal spray is changed, the traditional aspirin, ibuprofen, chlorphenamine and other antibiotic medicines are replaced by natural bactericidal and anti-inflammatory substances in plants such as eucalyptus leaves, bay leaves, sandalwood and the like, side effects on a human body are reduced, medicine resistance cannot be generated by bacteria in nasal cavities, a special preparation process is adopted to change the molecular selective permeability of the medicines, so that the spray forms a moisturizing membrane on the inner wall of the nasal cavity, the durability of cleaning and moisturizing the nasal cavity is improved on the premise that nasal germs are eliminated, the nasal cavity is kept clean and moist for a long time, the expected effect of the product is improved, and the pressure of a patient who is troubled to use the nasal spray is relieved better. In addition, the centipeda minima can treat stuffy nose and obstruction, nasosinusitis and watery nasal discharge, the menthol is used as an irritant in medicine and acts on skin or mucous membrane to achieve the effects of cooling and relieving itching, the magnolia flower can treat acute and chronic rhinitis, allergic rhinitis, hypertrophic rhinitis, nasosinusitis, paranasal sinusitis and the like, and the centipeda minima has the advantages of outstanding curative effect, high cure rate, simplicity, low cost and easiness in clinical popularization by matching with other medicinal auxiliary materials.
Example 2:
a nasal care spray characterized by: the composition is characterized by comprising the following raw materials in parts by weight: 7 parts of centipeda minima, 4 parts of eucalyptus leaf extract, 3 parts of bay leaf extract, 4 parts of sandalwood extract, 5 parts of magnolia flower, 6 parts of plant cellulose, 2 parts of radix scutellariae, 7 parts of radix sophorae flavescentis, 6 parts of wrinkled gianthyssop herb and 2 parts of isotonic regulator.
wherein the plant cellulose is prepared by mashing wheat bran and inorganic acid into slurry to obtain α -cellulose, treating to partially depolymerize cellulose, removing non-crystalline part, and purifying.
The Eucalyptus leaf extractive solution, the laurel leaf extractive solution and the sandalwood extractive solution are water saturated solutions prepared by respectively extracting fresh Eucalyptus leaf, laurel leaf and sandalwood leaf by a distillation extraction method.
Specifically, the preparation method of the nasal cavity care spray comprises the following steps:
step 1: mixing herba Centipedae, flos Magnoliae, plant cellulose, Scutellariae radix, radix Sophorae Flavescentis and herba Agastaches, pulverizing to 40-80 mesh, adding 8-12 times of 85% ethanol, soaking at 55-65 deg.C for 12-24 hr, filtering, and collecting filtrate; reflux-extracting the residue with 6-8 times of 95% ethanol at 65-85 deg.C for 5-7 hr, filtering, mixing filtrates, and concentrating under reduced pressure to 0.2-0.5g/ml to obtain solution A;
step 2: mixing the folium Eucalypti Globueli extractive solution, laurel leaf extractive solution and lignum Santali albi extractive solution at corresponding ratio, shaking at low frequency for 3-5 min, and filtering with filter to obtain solution B;
and step 3: mixing the obtained solution A and solution B, and oscillating at low frequency;
and 4, step 4: placing the isoosmotic adjusting agent into the mixed solution obtained in the step (3), and stirring the mixed solution for 3-5 minutes by using a magnetic stirrer;
and 5: carrying out electrode treatment on the mixed solution obtained in the step 4 every 3 minutes; the electrode treatment is to place the mixed reaction solution in a lower electrode medium of a plasma device with the voltage of 18kV, the current of 1.2mA and the gap of 3 mm;
step 6: and (5) sterilizing the solution obtained in the step (5), and sealing and preserving.
Finally, the solution is irradiated by an ultraviolet light source, and the microorganisms in the solution are killed.
According to the scheme, the type of a bactericide in the nasal spray is changed, the traditional aspirin, ibuprofen, chlorphenamine and other antibiotic medicines are replaced by natural bactericidal and anti-inflammatory substances in plants such as eucalyptus leaves, bay leaves, sandalwood and the like, side effects on a human body are reduced, medicine resistance cannot be generated by bacteria in nasal cavities, a special preparation process is adopted to change the molecular selective permeability of the medicines, so that the spray forms a moisturizing membrane on the inner wall of the nasal cavity, the durability of cleaning and moisturizing the nasal cavity is improved on the premise that nasal germs are eliminated, the nasal cavity is kept clean and moist for a long time, the expected effect of the product is improved, and the pressure of a patient who is troubled to use the nasal spray is relieved better.
Example 3:
a nasal care spray characterized by: the composition is characterized by comprising the following raw materials in parts by weight: 4 parts of eucalyptus leaf extract, 3 parts of laurel leaf extract, 4 parts of sandalwood extract, 5 parts of magnolia flower, 10 parts of menthol, 6 parts of plant cellulose, 2 parts of radix scutellariae, 7 parts of radix sophorae flavescentis, 6 parts of agastache rugosus and 2 parts of an isoosmotic adjusting agent.
wherein the plant cellulose is prepared by mashing wheat bran and inorganic acid into slurry to obtain α -cellulose, treating to partially depolymerize cellulose, removing non-crystalline part, and purifying.
The Eucalyptus leaf extractive solution, the laurel leaf extractive solution and the sandalwood extractive solution are water saturated solutions prepared by respectively extracting fresh Eucalyptus leaf, laurel leaf and sandalwood leaf by a distillation extraction method.
Specifically, the preparation method of the nasal cavity care spray comprises the following steps:
step 1: mixing flos Magnoliae, Mentholum, plant cellulose, Scutellariae radix, radix Sophorae Flavescentis, and herba Agastaches, pulverizing to 40-80 mesh, adding 8-12 times of 85% ethanol, soaking at 55-65 deg.C for 12-24 hr, filtering, and collecting filtrate; reflux-extracting the residue with 6-8 times of 95% ethanol at 65-85 deg.C for 5-7 hr, filtering, mixing filtrates, and concentrating under reduced pressure to 0.2-0.5g/ml to obtain solution A;
step 2: mixing the folium Eucalypti Globueli extractive solution, laurel leaf extractive solution and lignum Santali albi extractive solution at corresponding ratio, shaking at low frequency for 3-5 min, and filtering with filter to obtain solution B;
and step 3: mixing the obtained solution A and solution B, and oscillating at low frequency;
and 4, step 4: placing the isoosmotic adjusting agent into the mixed solution obtained in the step (3), and stirring the mixed solution for 3-5 minutes by using a magnetic stirrer;
and 5: carrying out electrode treatment on the mixed solution obtained in the step 4 every 3 minutes; the electrode treatment is to place the mixed reaction solution in a lower electrode medium of a plasma device with the voltage of 18kV, the current of 1.2mA and the gap of 3 mm;
step 6: and (5) sterilizing the solution obtained in the step (5), and sealing and preserving.
Finally, the solution is irradiated by an ultraviolet light source, and the microorganisms in the solution are killed.
According to the scheme, the type of a bactericide in the nasal spray is changed, the traditional aspirin, ibuprofen, chlorphenamine and other antibiotic medicines are replaced by natural bactericidal and anti-inflammatory substances in plants such as eucalyptus leaves, bay leaves, sandalwood and the like, side effects on a human body are reduced, medicine resistance cannot be generated by bacteria in nasal cavities, a special preparation process is adopted to change the molecular selective permeability of the medicines, so that the spray forms a moisturizing membrane on the inner wall of the nasal cavity, the durability of cleaning and moisturizing the nasal cavity is improved on the premise that nasal germs are eliminated, the nasal cavity is kept clean and moist for a long time, the expected effect of the product is improved, and the pressure of a patient who is troubled to use the nasal spray is relieved better.
Example 4:
a nasal care spray characterized by: the composition is characterized by comprising the following raw materials in parts by weight: 7 parts of centipeda minima, 4 parts of eucalyptus leaf extract, 3 parts of bay leaf extract, 4 parts of sandalwood extract, 5 parts of magnolia flower, 10 parts of menthol, 6 parts of plant cellulose, 2 parts of radix scutellariae, 7 parts of radix sophorae flavescentis, 6 parts of agastache rugosus and 2 parts of an isoosmotic adjusting agent.
wherein the plant cellulose is prepared by mashing wheat bran and inorganic acid into slurry to obtain α -cellulose, treating to partially depolymerize cellulose, removing non-crystalline part, and purifying.
The Eucalyptus leaf extractive solution, the laurel leaf extractive solution and the sandalwood extractive solution are water saturated solutions prepared by respectively extracting fresh Eucalyptus leaf, laurel leaf and sandalwood leaf by a distillation extraction method.
Specifically, the preparation method of the nasal cavity care spray comprises the following steps:
step 1: mixing herba Centipedae, flos Magnoliae, Mentholum, plant cellulose, Scutellariae radix, radix Sophorae Flavescentis and herba Agastaches, pulverizing to 40-80 mesh, adding 8-12 times of 85% ethanol, soaking at 55-65 deg.C for 12-24 hr, filtering, and collecting filtrate; reflux-extracting the residue with 6-8 times of 95% ethanol at 65-85 deg.C for 5-7 hr, filtering, mixing filtrates, and concentrating under reduced pressure to 0.2-0.5g/ml to obtain solution A;
step 2: mixing the folium Eucalypti Globueli extractive solution, laurel leaf extractive solution and lignum Santali albi extractive solution at corresponding ratio, shaking at low frequency for 3-5 min, and filtering with filter to obtain solution B;
and step 3: mixing the obtained solution A and solution B, and oscillating at low frequency;
and 4, step 4: placing the isoosmotic adjusting agent into the mixed solution obtained in the step (3), and stirring the mixed solution for 3-5 minutes by using a magnetic stirrer;
and 5: and (4) sterilizing the solution obtained in the step (4), and sealing and preserving.
Finally, the solution is irradiated by an ultraviolet light source, and the microorganisms in the solution are killed.
The spray prepared in the above example was tested using the following method: opening the dust cover, slightly lifting the head, extending the spray head into one side of the nostril for spraying for 2 times, and inhaling the nursing liquid into the body by inhaling the nasal cavity simultaneously during spraying so as to swallow the nursing liquid; changing the nostril at the other side, and repeating the above application method.
Group of Time to onset (average) Smooth duration (average)
Example 1 At once Half a day
Example 2 3min 2.2h
Example 3 3.5min 2.5h
Example 4 5min 30min
In addition, the comparison and the content show that the special preparation process adopted by the invention (wherein the electrode induction treatment is taken as a core technical point, the treatment greatly enhances the molecule selective permeability of the components of the essence with different compositions, so that the components of the essence of the spray are mutually fused and permeated), the components of the essence extracting solution of the spray are easier to permeate into the skin tissues of the nasal cavity, the durability of cleaning and moistening the nasal cavity is improved on the premise that the nasal cavity is cleared of germs of the product, the nasal cavity is kept clean and moist for a long time, the expected effect of the product is improved, the trouble pressure of using the nasal cavity spray by a patient is better relieved, and no side effect is caused.

Claims (5)

1. A nasal care spray characterized by: the composition is characterized by comprising the following raw materials in parts by weight: 6-8 parts of centipeda minima, 3-5 parts of eucalyptus leaf extract, 2-4 parts of bay leaf extract, 3-5 parts of sandalwood extract, 4-6 parts of magnolia flower, 8-12 parts of menthol, 5-7 parts of plant cellulose, 1-3 parts of radix scutellariae, 6-8 parts of radix sophorae flavescentis, 5-7 parts of agastache rugosus and 1-3 parts of isotonic regulator.
2. the nasal cavity care spray according to claim 1, wherein the plant cellulose is prepared by pulping wheat bran and a mineral acid to α -cellulose, partially depolymerizing the cellulose by treatment, removing non-crystalline parts, and purifying.
3. The nasal care spray according to claim 1, characterized in that: the Eucalyptus leaf extractive solution, the laurel leaf extractive solution and the sandalwood extractive solution are water saturated solutions prepared by respectively extracting fresh Eucalyptus leaf, laurel leaf and sandalwood leaf by a distillation extraction method.
4. A method of preparing a nasal care spray according to claims 1-3, characterized in that: the preparation method comprises the following steps:
step 1: mixing herba Centipedae, flos Magnoliae, Mentholum, plant cellulose, Scutellariae radix, radix Sophorae Flavescentis and herba Agastaches, pulverizing to 40-80 mesh, adding 8-12 times of 85% ethanol, soaking at 55-65 deg.C for 12-24 hr, filtering, and collecting filtrate; reflux-extracting the residue with 6-8 times of 95% ethanol at 65-85 deg.C for 5-7 hr, filtering, mixing filtrates, and concentrating under reduced pressure to 0.2-0.5g/ml to obtain solution A;
step 2: mixing the folium Eucalypti Globueli extractive solution, laurel leaf extractive solution and lignum Santali albi extractive solution at corresponding ratio, shaking at low frequency for 3-5 min, and filtering with filter to obtain solution B;
and step 3: mixing the obtained solution A and solution B, and oscillating at low frequency;
and 4, step 4: placing the isoosmotic adjusting agent into the mixed solution obtained in the step (3), and stirring the mixed solution for 3-5 minutes by using a magnetic stirrer;
and 5: carrying out electrode treatment on the mixed solution obtained in the step 4 every 3 minutes; the electrode treatment is to place the mixed reaction solution in a lower electrode medium of a plasma device with the voltage of 18kV, the current of 1.2mA and the gap of 3 mm;
step 6: and (5) sterilizing the solution obtained in the step (5), and sealing and preserving.
5. The nasal care spray according to claim 4, wherein: irradiating the obtained solution with ultraviolet light source to kill microorganisms in the solution.
CN202010163052.6A 2020-03-10 2020-03-10 Nasal cavity nursing spray and preparation method thereof Pending CN111214549A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010163052.6A CN111214549A (en) 2020-03-10 2020-03-10 Nasal cavity nursing spray and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010163052.6A CN111214549A (en) 2020-03-10 2020-03-10 Nasal cavity nursing spray and preparation method thereof

Publications (1)

Publication Number Publication Date
CN111214549A true CN111214549A (en) 2020-06-02

Family

ID=70808648

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010163052.6A Pending CN111214549A (en) 2020-03-10 2020-03-10 Nasal cavity nursing spray and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111214549A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106309558A (en) * 2016-09-20 2017-01-11 无比滴(广东)药业有限公司 Nasal spray
CN108852982A (en) * 2018-09-28 2018-11-23 上海百年吴越化妆品有限公司 A kind of paste cosmetic formulations and preparation method thereof
CN109394837A (en) * 2018-10-22 2019-03-01 吉林省七维生物科技有限公司 A kind of nasal mist and preparation method thereof
CN109431942A (en) * 2018-12-22 2019-03-08 上海百年吴越化妆品有限公司 A kind of acne-eliminating cosmetic Chinese medicine composition and preparation method thereof
CN109481429A (en) * 2019-01-22 2019-03-19 广州蓓思语生物科技有限公司 A kind of nasal nursing spray

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106309558A (en) * 2016-09-20 2017-01-11 无比滴(广东)药业有限公司 Nasal spray
CN108852982A (en) * 2018-09-28 2018-11-23 上海百年吴越化妆品有限公司 A kind of paste cosmetic formulations and preparation method thereof
CN109394837A (en) * 2018-10-22 2019-03-01 吉林省七维生物科技有限公司 A kind of nasal mist and preparation method thereof
CN109431942A (en) * 2018-12-22 2019-03-08 上海百年吴越化妆品有限公司 A kind of acne-eliminating cosmetic Chinese medicine composition and preparation method thereof
CN109481429A (en) * 2019-01-22 2019-03-19 广州蓓思语生物科技有限公司 A kind of nasal nursing spray

Similar Documents

Publication Publication Date Title
CN108272862B (en) Pudilan oral spray and preparation method thereof
CN105663243A (en) Traditional Chinese medicinal composition for treating rhinitis and/or nasosinusitis and drug of traditional Chinese medicinal composition
CN105232781A (en) Spray for removing bad breath, and preparation method thereof
CN103301254B (en) Antibacterial liquid used for nasopharyal meatus and preparation method thereof
CN112316017A (en) Gynecological antibacterial gel and preparation method thereof
CN113694024B (en) Physiological seawater nasal cavity sprayer
CN104258455B (en) A kind of medical bio antiseptic dressing and preparation method thereof
CN101129741A (en) Liquid for clearing heat and promoting eruption
CN110151915B (en) Propolis oral care solution and preparation method thereof
CN106309746A (en) Traditional Chinese medicine composition, preparation method thereof and oral health product
KR100735541B1 (en) A composition for cleaning nasal cavity and a method for preparing the same
CN111214549A (en) Nasal cavity nursing spray and preparation method thereof
CN107913234B (en) Pilose antler grass toothpaste and preparation method thereof
US20220193174A1 (en) Nasal spray for preventing influenza based on red pepper extract and heparin and preparation method thereof
CN108743497A (en) A kind of antibacterial mouthwash of plant source and preparation method thereof
CN112121116A (en) Natural plant active factor antibacterial atomizing agent and preparation method thereof
CN1923242A (en) Medicine for treating nasal cavity disease and preparation thereof
CN110604759A (en) Rhinitis spray and preparation method thereof
CN111388571A (en) Compound essential oil for treating rhinitis and cold
CN111407807A (en) Pharmaceutical composition for treating vasomotor rhinitis and preparation method thereof
CN110946816A (en) Natural herbal ulcer-removing oral and oral cavity spray
CN1197595C (en) Chinese medicine preparation for broad-spectrum inflammation relieving, disinfecting, erosion prevention and muscle growing
CN115554385B (en) Sheep-loosening herbal liquid
CN113633717B (en) Electronic atomized liquid composition for nasal cavity care, application thereof and obtained care product
CN107320652A (en) A kind of medicine spray for treating tinea pedis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200602